These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 6150491)
21. [Alternative therapy concept for the treatment of psychosomatic disorders. Controlled double-blind evaluation of fluspirilene versus bromazepam]. Lehmann E; Hassel P; Thörner GW; Karrass W Fortschr Med; 1984 Oct; 102(40):1033-6. PubMed ID: 6149989 [TBL] [Abstract][Full Text] [Related]
22. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone. Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and withdrawal of two potent benzodiazepines: bromazepam and lorazepam. Fontaine R; Annable L; Beaudry P; Mercier P; Chouinard G Psychopharmacol Bull; 1985; 21(1):91-2. PubMed ID: 2858908 [No Abstract] [Full Text] [Related]
24. [Clinical trial of bromazepam in hospital psychiatry (author's transl)]. Kress JJ; Maheo M; Cledes A; Chastaing A; Conan P Nouv Presse Med; 1982 May; 11(22):1735-7. PubMed ID: 6124946 [TBL] [Abstract][Full Text] [Related]
25. [Bromazepam in the treatment of somatized psychogenic disorders (author's transl)]. Podiwinsky F; Jellinger K Wien Klin Wochenschr; 1979 Mar; 91(7):240-4. PubMed ID: 34934 [TBL] [Abstract][Full Text] [Related]
26. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study of efficacy and withdrawal. Fontaine R; Chouinard G; Annable L Psychopharmacol Bull; 1984; 20(1):126-7. PubMed ID: 6144130 [No Abstract] [Full Text] [Related]
27. Bromazepam in generalized anxiety. Randomized, multi-practice comparisons with both chlorprothixene and placebo. Kragh-Sørensen P; Holm P; Fynboe C; Schaumburg E; Andersen B; Bech P; Pichard J Psychopharmacology (Berl); 1990; 100(3):383-6. PubMed ID: 1969172 [TBL] [Abstract][Full Text] [Related]
28. [A clinical trial of bromazepam (author's transl)]. Laxenaire M; Kahn JP; Marchand P Nouv Presse Med; 1982 May; 11(22):1699-701. PubMed ID: 6124936 [TBL] [Abstract][Full Text] [Related]
29. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial. Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097 [TBL] [Abstract][Full Text] [Related]
30. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety. Small GW; Bystritsky A J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045 [TBL] [Abstract][Full Text] [Related]
31. [Anxiety in ambulatory and hospital practice: effects of a new anxiolytic agent, bromazepam, in a homogeneous series of 30 patients (author's transl)]. Billé J; Dalmas C Nouv Presse Med; 1982 May; 11(22):1706-9. PubMed ID: 6124938 [TBL] [Abstract][Full Text] [Related]
39. [A new anxiolytic: Lexotanil (Ro 5-3350)]. Remy M Rev Med Suisse Romande; 1975 Jun; 95(6):479-87. PubMed ID: 4878 [No Abstract] [Full Text] [Related]
40. [Clinical testing of a new benzodiazepine, bromazepam, in a double blind test with thioridazine]. Mironi F; Saccardo M; Lion P Riv Neurobiol; 1972; 18(3-4):257-66. PubMed ID: 4157046 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]